AnjaliDasKevinLyMohanika Gowda Shivani Shah

A non-invasive portable glucose monitor

using near-infrared spectroscopy

10% MARKET SHARE

Executive Summary

26million diabetics in the US79million in the prediabetic stage in the US285million adults worldwide with diabetes

Significance and Market Analysis

Significance and Market AnalysisCompetition

Proposed plan

ReliabilityReliability

SatisfactionSatisfaction

TeamworkTeamwork

EaseofUseEaseofUse“Ourmissionisto

manufacturesafeandreliable,easytouseglucosemonitoring

products.“

Our Company

BOARDOFDIRECTORS

CorporateTechnicalDirector

CorporateTechnicalDirector

DirectorofHumanResources

DirectorofHumanResourcesManufacturingDepartmentManufacturingDepartment

DepartmentofIntellectualDesignandResearch

DepartmentofIntellectualDesignandResearch

DirectionofCorporateBusinessDevelopmentDirectionofCorporateBusinessDevelopment

DepartmentofStrategicCommunications

DepartmentofStrategicCommunications

SalesDepartmentSalesDepartment

CorporateInfrastructureCorporateInfrastructure

DepartmentofBudgetingDepartmentofBudgeting

OfficeofRiskManagementOfficeofRiskManagement

CORPORATEMANAGEMENT

Chairman:Dr.DhawanChairman:Dr.Dhawan

ExecutiveManagementTeam

ExecutiveManagementTeam ConsultantsConsultants External

AdvisoryBoardExternal

AdvisoryBoardPresident/CEOShivani ShahPresident/CEOShivani Shah

ChiefResearch,Sales,Marketing,TechnicalSupportOfficer:KevinLy

ChiefResearch,Sales,Marketing,TechnicalSupportOfficer:KevinLy

ChiefOperationsOfficer:Mohanika Gowda

ChiefOperationsOfficer:Mohanika Gowda

ChiefFinanceOfficer:AnjaliDas

ChiefFinanceOfficer:AnjaliDas

DivisionalOperationalManagers

DivisionalOperationalManagers

CorporatePurchasingDirector

CorporatePurchasingDirector

DivisionalITandSoftwareDevelopmentManagersDivisionalITandSoftwareDevelopmentManagers

DivisionalEngineeringManagers

DivisionalEngineeringManagers

FieldTechnicalServiceFieldTechnicalService

CorporateComptrollerCorporateComptroller

Business Management Plan

Gantt and Milestones

Obtain financing through IDS & Summer Research Provost AwardComplete Business and Technical Plans

Identify glucose fingerprint spectraHardware prototype developmentSoftware prototype developmentMonitor Progress with EAB Review

Initiate Patenting and Securitization of Intellectual Property ProcessPrototype EvaluationInitiate testing of prototype Monitor Progress with EAB Review

Model and Design Software testingMonitor Progress with EAB Review

Refinement of designMonitor Progress with EAB ReviewOrganization/Planning of Manufacturing

Finalize contracts with 3 channels/vendorsDevelop infrastructure for Production

Research other applicationsProduction

Achieve Maximum capacity for 5%

2012 2013 2014 2015 2016 2011

RequiredStart‐UpFunds Amount TotalsFixedAssets

RealEstate‐Land $‐Buildings ‐LeaseholdImprovements $15,000Equipment $10,000FurnitureandFixtures $10,000Vehicles $30,000OtherFixedAssets $5,000

TotalFixedAssets $70,000

OperatingCapitalPre‐OpeningSalariesandWages $200,000PrepaidInsurancePremiums $20,200Inventory $1,000LegalandAccountingFees $19,000RentDeposits $8,000UtilityDeposits $300Supplies $2,000AdvertisingandPromotions ‐Licenses ‐OtherInitialStart‐UpCosts $5,000WorkingCapital(CashOnHand) $30,000

TotalOperatingCapital $285,500

TotalRequiredFunds $355,500

Sources of Funding Amount Totals

Owner's Equity 0.00 % -

Outside Investors 56.26 % $ 200,000 Additional Loans or Debt

Commercial Loan 43.74 % $ 155,500

Commercial Mortgage 0.00 % -

Credit Card Debt 0.00 % -

Vehicle Loans 0.00 % -

Other Bank Debt 0.00 % -

Total Sources of Funding 100.00 % $ 355,500

Financial Plan: Start-Up Funds

Financial Plan: Break Even Projections

ProductPricePerUnit $ 1,000.00 100.00%

VariableCostPerUnit $ 400.00 40.00%GrossMarginPerUnit $600.00 60.00%

Year1ofProduction 6,000unitsYear2ofProduction 12,000unitsYear3ofProduction 26,400units

$0

$6,000,000

$729,000

$4,448,311

$0

$1,000,000

$2,000,000

$3,000,000

$4,000,000

$5,000,000

$6,000,000

$7,000,000

1 2 3

Dol

lars

Year

BreakevenbetweenY1‐Y2ofProduction

Sales Cost

Breakeven:$831,915

BreakevenSalesRevenue $831,915.43BreakevenSalesUnits 832

$0

$5,000,000

$10,000,000

$15,000,000

$20,000,000

$25,000,000

$30,000,000

0 2 4 6

Dol

lars

Year

Cost vs Sales Projection

Sales

Cost

GainSummerResearchFunding $2,800ObtainPhase1FundingIdentifyspectralfingerprintforglucoseinbloodDevelopprototypeTestaccuracyofprototypeagainstcurrentglucometers

Phase 1: Project Goals

• SoftwareandProductParameters

• Easeofuse

• Accuracy

• Responsiveness

• Addressingneedsofusers

• Portability

• Durability

• Intuitiveness

• TestsinaccordancewiththeInternationalOrganizationforStandardization(ISO)

• AccuracydeterminedbyClark/ConsensusErrorGridAnalysis

• FocusGrouptestingofsoftwareandproduct

• ClinicalTrialsandFDAapproval

• Determineprogressagainstsetmilestones• SemiannualEvaluationsbyExternalAdvisoryBoard

ProductEvaluation

BusinessEvaluation

Phase 1: Evaluation Plan

$6,000SeedMoneyforPhase1Research$3,000 forequipmentexpenses

–SonyCCDcamera–NIRfilters–GlucoseSolutions

$1,000 for R&DSupplies$2,000forPrototypeManufacturingandotherExpenses

AllothermaterialsandadvicenecessaryprovidedbyIDSprogram,HonorsCollege,and NJIT

Phase 1: IDS Budget

WewouldliketothankDr.Dhawan,Dr.Sava,Dr.Dine,andDr.Bloomforprovidinguswiththeresourcesandtheguidancetomakethispossible.

WewouldalsoliketothankmembersoftheExternalAdvisoryBoardforsharingtheirtimeandexpertisetodayandinearlierguestspeakerarrangementsthissemester.

Acknowledgements